RG
Redmile Group Portfolio holdings
AUM
$1.36B
1-Year Est. Return
111.01%
This Fund
S&P 500
1 Year Est. Return
+111.01%
AUM
$1.36B
AUM Growth
+$330M
(+32%)
Holding
43
Top Buys
| 1 | +$63.4M | |
| 2 | +$49.4M | |
| 3 | +$14.3M | |
| 4 |
Immunome
IMNM
|
+$12.2M |
| 5 |
RAPT Therapeutics
RAPT
|
+$10.4M |
Top Sells
| 1 | +$70.1M | |
| 2 | +$46.2M | |
| 3 | +$35.5M | |
| 4 |
Cogent Biosciences
COGT
|
+$21.7M |
| 5 |
ETNB
89bio
ETNB
|
+$21.7M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Scholar Rock
SRRK
$4.52B
| $230M | 16.94% |
5,220,846
+1,316,390
|
|
||
2
Krystal Biotech
KRYS
$8.06B
| $167M | 12.3% |
677,705
+16,317
|
|
||
3
Nurix Therapeutics
NRIX
$1.64B
| $154M | 11.31% |
8,093,908
+4,415,514
|
|
||
4
Stoke Therapeutics
STOK
$2.08B
| $128M | 9.43% |
4,034,070
-141,472
|
|
||
|
5
Immunome
IMNM
$2.41B
| $123M | 9.05% |
5,718,385
+695,000
|
|
||
6
Regenxbio
RGNX
$458M
| $62.9M | 4.63% |
4,368,804
-324,585
|
|
||
7
ADC Therapeutics
ADCT
$508M
| $55.3M | 4.07% |
15,666,731
|
|
||
|
8
Cogent Biosciences
COGT
$6.31B
| $51.1M | 3.76% |
1,437,918
-771,200
|
|
||
9
Annexon
ANNX
$835M
| $50.5M | 3.72% |
10,050,644
+3,750,000
|
|
||
10
Beam Therapeutics
BEAM
$2.89B
| $35.6M | 2.62% |
1,285,859
-101,700
|
|
||
11
Neurogene
NGNE
$364M
| $30.1M | 2.21% |
1,459,599
+160,577
|
|
||
|
12
RAPT Therapeutics
RAPT
$1.68B
| $30M | 2.21% |
885,927
+333,333
|
|
||
13
Absci
ABSI
$412M
| $28.8M | 2.12% |
8,253,316
|
|
||
14
Nuvation Bio
NUVB
$2.03B
| $28.3M | 2.09% |
3,163,256
+132,247
|
|
||
15
IDEAYA Biosciences
IDYA
$2.83B
| $25.7M | 1.89% |
742,017
|
|
||
16
Shattuck Labs
STTK
$248M
| $20.2M | 1.49% |
5,539,724
|
|
||
|
SLN
17
Silence Therapeutics
SLN
$257M
| $13.2M | 0.97% |
2,164,777
|
|
||
18
Zymeworks
ZYME
$1.76B
| $12.9M | 0.95% |
491,654
-3,214,096
|
|
||
19
Fate Therapeutics
FATE
$171M
| $12.6M | 0.93% |
12,872,946
|
|
||
20
Replimune Group
REPL
$632M
| $10.7M | 0.79% |
1,099,756
+563,938
|
|
||
|
DBVT
21
DBV Technologies
DBVT
$1.15B
| $10.5M | 0.78% |
+549,840
|
|
||
22
Solid Biosciences
SLDB
$484M
| $10.5M | 0.77% |
1,860,542
-38,800
|
|
||
|
CBLL
23
CeriBell Inc
CBLL
$693M
| $9.54M | 0.7% |
435,239
|
|
||
24
Establishment Labs
ESTA
$2.29B
| $8.21M | 0.6% |
112,664
-16,700
|
|
||
25
Atara Biotherapeutics
ATRA
$39.1M
| $7.99M | 0.59% |
441,701
|
|